3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow relacorilant: new trials by email Literature Review of relacorilant trials Research Report on relacorilant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Relacorilant, Nab-paclitaxel - Recurrent Ovarian Cancer, Recurrent Fallopian Tube Carcinoma | Phase 2 | Completed | Corcept Therapeutics | 178 | 2019-04-05 | 2025-10-07 |
| Study to Evaluate CORT125134 in Participants With Cushing's Syndrome CORT125134 - Cushing's Syndrome | Phase 2 | Completed | Corcept Therapeutics | 35 | 2016-06-01 | 2019-10-15 |
| Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors Relacorilant with nab-paclitaxel - Solid Tumors | Phase 1 / Phase 2 | Completed | Corcept Therapeutics | 85 | 2016-05-23 | 2022-12-06 |
ACTH Syndrome, Ectopic (1) · Adrenal Cortex Neoplasms (1) · Adrenocortical Carcinoma (1) · Carcinoma, Ovarian Epithelial (1) · Cushing Syndrome (1) · Diabetes Mellitus, Type 2 (1) · Fallopian Tube Neoplasms (1) · Hypertension (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Pituitary ACTH Hypersecretion (1) · Triple Negative Breast Neoplasms (1)
United States (3) · Italy (2) · Belgium (1) · Canada (1) · Hungary (1) · Netherlands (1) · Spain (1) · United Kingdom (1)
Andreas G Moraitis, MD (1) · Sachin Pai, MD (1)